BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)
Clinical trial NCT01750918 · COMPLETED
Trial details
- NCT number
- NCT01750918
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-19
- Primary completion
- 2020-06-18
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.